(Q35753471)

10 August 2017

title

Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model (English)

1 reference

10 August 2017

0 references

0 references

1 reference

1 reference

10

Bruno Pradines

1 reference

10 August 2017

9

Christophe Rogier

1 reference

10 August 2017

2

Sébastien Briolant

1 reference

10 August 2017

4

Joel Mosnier

1 reference

10 August 2017

7

Rémy Amalvict

1 reference

10 August 2017

6

Eric Baret

1 reference

10 August 2017

Jean-Baptiste Souraud

series ordinal

1

object named as

Jean-Baptiste Souraud

1 reference

10 August 2017

5

Hélène Savini

1 reference

10 August 2017

Jérome Dormoi

3

1 reference

10 August 2017

Raoulin Soulard

series ordinal

8

1 reference

10 August 2017

publication date

10 January 2012

1 reference

10 August 2017

1 reference

10 August 2017

volume

11

1 reference

10 August 2017

page(s)

13

1 reference

https://scigraph.springernature.com/pub.10.1186/1475-2875-11-13

10 August 2017

exact match

0 references

cites work

Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Artemisinin Resistance in Plasmodium falciparum Malaria

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Statins inhibit NK-cell cytotoxicity by interfering with LFA-1-mediated conjugate formation.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Statins for sepsis: a critical and updated review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Diagnosis and management of the neurological complications of falciparum malaria

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Challenges in the determination of early predictors of cerebral malaria: lessons from the human disease and the experimental murine models

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Cerebral malaria in children is associated with long-term cognitive impairment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Gene expression analysis reveals early changes in several molecular pathways in cerebral malaria-susceptible mice versus cerebral malaria-resistant mice

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Statins and sepsis: multiple modifications at multiple levels.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Adjuvant therapy in cerebral malaria

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Pathogenic T cells in cerebral malaria

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Conquering the intolerable burden of malaria: what's new, what's needed: a summary.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Pathogenesis of malaria and clinically similar conditions

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Simvastatin decreases nitric oxide overproduction and reverts the impaired vascular responsiveness induced by endotoxic shock in rats

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Evidence for multiple pathologic and protective mechanisms of murine cerebral malaria.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Atorvastatin is a promising partner for antimalarial drugs in treatment of Plasmodium falciparum malaria

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells

12 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2875-11-13

Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2875-11-13

Statin treatment after onset of sepsis in a murine model improves survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2875-11-13

HMG-CoA reductase inhibitors improve acute ischemic stroke outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2875-11-13

Simvastatin treatment shows no effect on the incidence of cerebral malaria or parasitemia during experimental malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2875-11-13

Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2875-11-13

Atorvastatin as a potential antimalarial drug: in vitro synergy in combinational therapy with dihydroartemisinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2875-11-13

Behavioural and histopathological alterations in mice with cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2875-11-13

Statins alone are ineffective in cerebral malaria but potentiate artesunate

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2875-11-13

Statins fail to improve outcome in experimental cerebral malaria and potentiate Toll-like receptor-mediated cytokine production by murine macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2875-11-13

Plasmodium berghei: cerebral malaria in CBA mice is not clearly related to plasma TNF levels or intensity of histopathological changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2875-11-13

Neuronal apoptosis, metallothionein expression and proinflammatory responses during cerebral malaria in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1475-2875-11-13

NK cells stimulate recruitment of CXCR3+ T cells to the brain during Plasmodium berghei-mediated cerebral malaria.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Perforin-dependent brain-infiltrating cytotoxic CD8+ T lymphocytes mediate experimental cerebral malaria pathogenesis

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3278339

Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis

25 September 2018

1 reference

12 December 2020

Statins as a newly recognized type of immunomodulator

1 reference

12 December 2020

Pravastatin down-regulates inflammatory mediators in human monocytes in vitro

1 reference

12 December 2020

Validated HPLC-MS-MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma-pharmacokinetic study

1 reference

12 December 2020

Identifiers

DOI

10.1186/1475-2875-11-13

1 reference

Dimensions Publication ID

10 August 2017

0 references

1 reference

10 August 2017

1 reference